🇺🇸 FDA
Pipeline program

Dobutamine

Dobutamine

Unknown small_molecule completed

Quick answer

Dobutamine for Patients With Septic Shock is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Patients With Septic Shock
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials